+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Legionella Testing Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797887
The global legionella testing market size attained a value of USD 288.1 million in 2022. The market is likely to grow at a CAGR of 8.20% during the forecast period of 2023-2031 to attain a value of USD 585.6 million by 2031.

Legionella Testing Market: Introduction

Legionella testing is the process of detecting and identifying the presence of Legionella bacteria in water systems, such as cooling towers, hot and cold-water systems, and other water-related environments. Legionella is a potentially dangerous bacterium that can cause Legionnaires' disease, a severe and sometimes fatal form of pneumonia, as well as Pontiac fever, a milder, flu-like illness. Legionella testing is crucial for preventing and controlling outbreaks of these diseases, as it helps ensure the safety of water systems in various settings, such as residential buildings, healthcare facilities, and industrial plants.

There are several methods used for Legionella testing, including culture testing, polymerase chain reaction (PCR) testing, and rapid antigen testing. Culture testing, the gold standard for Legionella detection, involves taking water samples and cultivating them on a specialized growth medium that encourages the growth of Legionella bacteria. This method allows for the identification of specific Legionella species and quantification of the bacterial concentration in the sample. PCR testing, on the other hand, detects the presence of Legionella DNA in water samples, providing a quicker result but lacking the ability to quantify the bacteria or distinguish between live and dead cells. Rapid antigen testing utilizes immunoassays to detect the presence of Legionella antigens in water samples, offering a fast and convenient screening method but with reduced sensitivity compared to culture testing.

Legionella testing is essential for several reasons. Firstly, it helps ensure compliance with local and international regulations and guidelines related to the prevention and control of Legionnaires' disease. Regular testing of water systems can identify the presence of Legionella bacteria, enabling prompt remediation and reducing the risk of disease transmission.

Additionally, Legionella testing is crucial for maintaining a safe environment in facilities with vulnerable populations, such as hospitals, nursing homes, and other healthcare settings. People with weakened immune systems, chronic lung disease, or other underlying health conditions are at higher risk for developing severe Legionnaires' disease, making the prevention of Legionella exposure especially important in these environments.

Legionella testing is used to evaluate the effectiveness of water treatment and disinfection measures, providing valuable information on the success of control strategies and informing adjustments to these strategies as needed. By regularly testing water systems for the presence of Legionella, facility managers and public health officials can monitor and maintain the safety of water supplies and protect the health of those who rely on them.

Legionella Testing Market Segmentations

The market can be categorised into segments like type, test, end user, and major region.

Market Breakup by Type

  • Culture Methods
  • UAT
  • Serology
  • DFA Test
  • Nucleic Acid-Based Detection
  • PCR

Market Breakup by Test

  • Water Testing
  • Microbial Culture
  • DFA Stain
  • PCR
  • Others
  • IVD Testing
  • Blood Culture
  • Urine Antigen Test
  • DFA Stain
  • PCR
  • Others

Market Breakup by End User

  • Hospital and Clinics
  • Diagnostic Laboratories

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others
Legionella Testing Market

The global Legionella testing market has been experiencing steady growth in recent years and is expected to continue expanding due to several factors, such as increased awareness of Legionella-associated diseases, stricter regulations and guidelines, technological advancements in testing methods, and the rising demand for rapid and accurate diagnostic solutions.

Increased awareness of the risks associated with Legionella bacteria and the potential consequences of Legionnaires' disease and Pontiac fever has led to a greater emphasis on the importance of regular testing of water systems. Governments, regulatory bodies, and public health organizations worldwide have implemented stricter guidelines and regulations to ensure the safety of water systems in various settings, including residential buildings, healthcare facilities, industrial plants, and hotels. These regulations have driven the demand for Legionella testing services, as facility owners and operators seek to maintain compliance and protect the health of occupants and users.

Technological advancements in Legionella testing methods have also contributed to the growth of the market. The development of more sensitive, accurate, and rapid testing techniques, such as PCR and rapid antigen tests, has made it easier for organizations to implement Legionella testing as part of their routine water management programs. These newer testing methods have not only improved the detection capabilities but also reduced the turnaround time for results, enabling faster responses to potential outbreaks and increasing the overall efficiency of water safety programs.

The global Legionella testing market is also fuelled by the rising demand for diagnostic solutions that can help prevent and control outbreaks of Legionnaires' disease and Pontiac fever. With an aging population and an increasing number of people with weakened immune systems or chronic health conditions, the need for effective testing and monitoring of water systems has become even more critical. This growing demand has led to the expansion of the market, with more companies offering Legionella testing services and a broader range of testing options available to consumers.

Despite the overall positive outlook for the Legionella testing market, there are some challenges that may impact its growth, such as the high costs associated with testing and the lack of standardized testing protocols across different regions. However, the continued emphasis on public health, water safety, and technological advancements is expected to drive the market forward, as the importance of Legionella testing in maintaining safe water systems and preventing disease outbreaks becomes increasingly recognized.

Key Players in the Global Legionella Testing Market

The report gives an in-depth analysis of the key players involved in the legionella testing market. The companies included in the market are as follows:
  • Abbott Laboratories
  • Alere Inc
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc
  • bioMerieux S.A
  • Beckman Coulter, Inc
  • Eiken Chemical Co., Ltd
  • Hologic, Inc
  • Pro-lab Diagnostics, Inc
  • Roche Diagnostics
  • Takara Bio, Inc
  • Thermo Fischer Scientific, Inc.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Legionnaires disease Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Diabetes Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Legionnaires Epidemiology (2016-2031)
5.3 Europe Legionnaires Epidemiology (2016-2031)
5.4 Asia-Pacific Legionnaires Epidemiology (2016-2031)
5.5 Latin America Legionnaires Epidemiology (2016-2031)
5.6 Middle East & Africa Legionnaires Epidemiology (2016-2031)
6 Global Legionella Testing Market Overview
6.1 Global Legionella Testing Market Historical Value (2016-2022)
6.2 Global Legionella Testing Market Forecast Value (2023-2031)
7 Global Legionella Testing Market Landscape
7.1 Global Legionella Testing Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Global Legionella Testing Product Landscape
7.2.1 Analysis by Type
7.2.2 Analysis by Test
7.2.3 Analysis by End User
8 Legionella Testing Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Legionella Testing Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Legionella Testing Market Segmentation
11.1 Global Legionella Testing Market by Type
11.1.1 Market Overview
11.1.2 Culture Methods
11.1.3 UAT
11.1.4 Serology
11.1.5 DFA Test
11.1.6 Nucleic Acid-Based Detection
11.1.7 PCR
11.2 Global Legionella Testing Market by Test
11.2.1 Market Overview
11.2.2 Water Testing Microbial Culture DFA Stain PCR Others Others
11.2.3 IVD Testing Blood Culture Urine Antigen Test DFA Stain PCR Others
11.3 Global Legionella Testing Market by End User
11.3.1 Market Overview
11.3.2 Hospital & Clinics
11.3.3 Diagnostic Laboratories
11.4 Global Legionella Testing Market by Region
11.4.1 Market Overview
11.4.2 North America
11.4.3 Europe
11.4.4 Asia Pacific
11.4.5 Latin America
11.4.6 Middle East and Africa
12 North America Legionella Testing Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Legionella Testing Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Legionella Testing Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Legionella Testing Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Legionella Testing Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Patent Analysis
17.1 Analysis by Type of Patent
17.2 Analysis by Publication year
17.3 Analysis by Issuing Authority
17.4 Analysis by Patent Age
17.5 Analysis by CPC Analysis
17.6 Analysis by Patent Valuation
17.7 Analysis by Key Players
18 Grants Analysis
18.1 Analysis by year
18.2 Analysis by Amount Awarded
18.3 Analysis by Issuing Authority
18.4 Analysis by Grant Application
18.5 Analysis by Funding Institute
18.6 Analysis by NIH Departments
18.7 Analysis by Recipient Organization
19 Clinical Trials Analysis
19.1 Analysis by Trial Registration Year
19.2 Analysis by Trial Status
19.3 Analysis by Trial Phase
19.4 Analysis by Therapeutic Area
19.5 Analysis by Geography
20 Funding Analysis
20.1 Analysis by Funding Instances
20.2 Analysis by Type of Funding
20.3 Analysis by Funding Amount
20.4 Analysis by Leading Players
20.5 Analysis by Leading Investors
20.6 Analysis by Geography
21 Partnership and Collaborations Analysis
21.1 Analysis by Partnership Instances
21.2 Analysis by Type of Partnership
21.3 Analysis by Leading Players
21.4 Analysis by Geography
22 Regulatory Framework
22.1 Regulatory Overview
22.1.1 US FDA
22.1.2 EU EMA
22.1.5 Others
23 Supplier Landscape
23.1 Abbott Laboratories
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Alere Inc.
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Becton, Dickinson and Company (BD)
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Bio-Rad Laboratories, Inc.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 bioMerieux S.A.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Beckman Coulter, Inc.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Eiken Chemical Co., Ltd
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Hologic, Inc.
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Pro-lab Diagnostics, Inc.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 QIAGEN
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Roche Diagnostics
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Takara Bio, Inc.
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Thermo Fischer Scientific, Inc.
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
24 Global Legionella Testing Market- Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket

Companies Mentioned

  • Abbott Laboratories
  • Alere Inc.
  • Becton, Dickinson and Company (Bd)
  • Bio-Rad Laboratories, Inc.
  • Biomerieux S.A.
  • Beckman Coulter, Inc.
  • Eiken Chemical Co. Ltd
  • Hologic, Inc.
  • Pro-Lab Diagnostics, Inc.
  • Qiagen
  • Roche Diagnostics
  • Takara Bio, Inc.
  • Thermo Fischer Scientific, Inc.



Table Information